|
Matthew Gehl is an associate in the firm’s New York office and a member of the Corporate Practice Group. He practices corporate and securities law, with a focus on the representation of underwriters and issuers in equity and debt capital markets transactions. He also advises clients on disclosure and other securities laws issues, corporate governance matters and other general corporate matters.
Representative Matters
- Representing the underwriters in the pending initial public offering of a biopharmaceutical company focused on monoclonal antibody therapeutics targeting cancer stem cells.
- Represented the underwriters in offerings by a leading manufacturer and marketer of consumer and professional products of an aggregate of $900 million of investment-grade notes.
- Represented the underwriters in the $54 million initial public offering and subsequent $79 million follow-on offering of a life sciences company in the human genome sequencing and analysis space.
- Represented the underwriters in a $76 million registered equity follow-on offering by a developer and marketer of aesthetic laser treatment systems and a selling stockholder.
- Represented the underwriters in numerous offerings of an aggregate of approximately $2.4 billion of registered equity and debt securities of real estate investment trusts in the health care and senior living industries.
- Represented the underwriters in multiple public offerings of investment-grade notes and common stock of a large financial services firm totaling approximately $2.8 billion.
- Represented a manufacturer of specialty metal products in a $130 million Rule 144A/Reg S offering of senior secured notes.
Publications and Speeches
|